CareDx Cost of Goods Sold 2013-2025 | CDNA
CareDx cost of goods sold from 2013 to 2025. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
| CareDx Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024 | $110 |
| 2023 | $102 |
| 2022 | $112 |
| 2021 | $97 |
| 2020 | $63 |
| 2019 | $45 |
| 2018 | $33 |
| 2017 | $21 |
| 2016 | $21 |
| 2015 | $10 |
| 2014 | $9 |
| 2013 | $9 |
| 2012 | $8 |
| CareDx Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2025-03-31 | $28 |
| 2024-12-31 | $28 |
| 2024-09-30 | $28 |
| 2024-06-30 | $28 |
| 2024-03-31 | $26 |
| 2023-12-31 | $26 |
| 2023-09-30 | $25 |
| 2023-06-30 | $26 |
| 2023-03-31 | $26 |
| 2022-12-31 | $29 |
| 2022-09-30 | $28 |
| 2022-06-30 | $28 |
| 2022-03-31 | $27 |
| 2021-12-31 | $27 |
| 2021-09-30 | $25 |
| 2021-06-30 | $24 |
| 2021-03-31 | $22 |
| 2020-12-31 | $19 |
| 2020-09-30 | $17 |
| 2020-06-30 | $15 |
| 2020-03-31 | $12 |
| 2019-12-31 | $13 |
| 2019-09-30 | $11 |
| 2019-06-30 | $12 |
| 2019-03-31 | $10 |
| 2018-12-31 | $11 |
| 2018-09-30 | $9 |
| 2018-06-30 | $7 |
| 2018-03-31 | $6 |
| 2017-12-31 | $6 |
| 2017-09-30 | $5 |
| 2017-06-30 | $5 |
| 2017-03-31 | $5 |
| 2016-12-31 | $6 |
| 2016-09-30 | $6 |
| 2016-06-30 | $6 |
| 2016-03-31 | $3 |
| 2015-12-31 | $2 |
| 2015-09-30 | $3 |
| 2015-06-30 | $3 |
| 2015-03-31 | $3 |
| 2014-12-31 | $2 |
| 2014-09-30 | $2 |
| 2014-06-30 | $2 |
| 2014-03-31 | $2 |
| 2013-12-31 | $2 |
| 2013-09-30 | $3 |
| 2013-06-30 | $2 |
| 2013-03-31 | $2 |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.712B | $0.334B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.316B | 26.95 |
| CVS Health (CVS) | United States | $75.446B | 9.38 |
| Elevance Health (ELV) | United States | $64.396B | 8.66 |
| Cencora (COR) | United States | $55.472B | 19.30 |
| DiDi Global (DIDIY) | China | $25.980B | 27.60 |
| Labcorp Holdings (LH) | United States | $21.919B | 17.30 |
| Natera (NTRA) | United States | $18.843B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| ICON (ICLR) | Ireland | $15.316B | 14.74 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.929B | 0.00 |
| CochLear (CHEOY) | Australia | $13.403B | 0.00 |
| Solventum (SOLV) | United States | $12.763B | 13.51 |
| Medpace Holdings (MEDP) | United States | $12.728B | 33.68 |
| Revvity (RVTY) | United States | $11.202B | 19.44 |
| Viatris (VTRS) | United States | $10.868B | 3.73 |
| Avantor (AVTR) | United States | $9.533B | 13.85 |
| Sonic Healthcare (SKHHY) | Australia | $9.208B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.791B | 17.23 |
| HealthEquity (HQY) | United States | $8.281B | 36.27 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.884B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.109B | 30.08 |
| BrightSpring Health Services (BTSG) | United States | $3.600B | 33.03 |
| Sotera Health (SHC) | United States | $3.489B | 19.82 |
| Surgery Partners (SGRY) | United States | $2.876B | 37.40 |
| Organon (OGN) | United States | $2.592B | 2.75 |
| Concentras Parent (CON) | United States | $2.576B | 14.89 |
| GeneDx Holdings (WGS) | United States | $2.423B | 93.31 |
| Alignment Healthcare (ALHC) | United States | $2.346B | 0.00 |
| Progyny (PGNY) | United States | $1.989B | 43.77 |
| PACS (PACS) | United States | $1.792B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.789B | 35.79 |
| Premier (PINC) | United States | $1.739B | 13.20 |
| Ardent Health (ARDT) | United States | $1.525B | 6.50 |
| Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.228B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.088B | 8.28 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.824B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.753B | 7.05 |
| Embecta (EMBC) | United States | $0.662B | 4.46 |
| Nutex Health (NUTX) | United States | $0.513B | 7.77 |
| So-Young (SY) | China | $0.513B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.506B | 0.00 |
| LifeMD (LFMD) | United States | $0.494B | 0.00 |
| Omada Health (OMDA) | $0.478B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.477B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.457B | 10.28 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.406B | 0.00 |
| Enhabit (EHAB) | United States | $0.344B | 28.29 |
| Oncology Institute (TOI) | United States | $0.336B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.286B | 0.00 |
| Beauty Health (SKIN) | United States | $0.222B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.204B | 0.00 |
| DocGo (DCGO) | United States | $0.152B | 24.83 |
| Sera Prognostics (SERA) | United States | $0.118B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| KindlyMD (NAKA) | United States | $0.077B | 0.00 |
| Biodesix (BDSX) | United States | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |